Method and compositions for identifying anti-hiv therapeutic compounds
First Claim
Patent Images
1. A method comprising (a) identifying a non-nucleotide prototype compound;
- (b) substituting the prototype compound with a phosphonate-containing group to produce a candidate compound; and
(a) determining the anti-HIV activity of the candidate compound.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods are provided for identifying anti-HIV therapeutic compounds substituted with carboxyl ester or phosphonate ester groups. Libraries of such compounds are screened optionally using the novel enzyme GS-7340 Ester Hydrolase. Compositions and methods relating to GS-7340 Ester Hydrolase also are provided.
-
Citations
70 Claims
-
1. A method comprising
(a) identifying a non-nucleotide prototype compound; -
(b) substituting the prototype compound with a phosphonate-containing group to produce a candidate compound; and
(a) determining the anti-HIV activity of the candidate compound. - View Dependent Claims (3, 4, 7, 8, 10, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 27, 28, 29, 30)
-
-
2. A method comprising
(a) selecting a non-nucleotide candidate compound containing at least one esterified carboxyl or esterified phosphonate-containing group; - and
(b) determining the intracellular persistence of the candidate compound or a esterolytic metabolite of the esterified carboxyl or phosphonate-containing group thereof. - View Dependent Claims (5, 6, 9, 11, 25, 26, 31, 32, 33, 34, 35, 36, 37)
- and
- 38. A library of candidate non-nucleotide anti-HIV compounds comprising a plurality of candidate compounds suspected to have anti HIV activity which contain esterified carboxyl or esterified phosphonate groups.
- 39. A library of candidate anti-HIV compounds which does not consist solely of nucleotides and which comprises a plurality of candidate compounds suspected to have anti-HIV activity which contain esterified carboxyl or esterified phosphonate groups.
- 46. Isolated GS-7340 Ester Hydrolase.
- 50. The Hydrolase of claim 50 which has a pl of about 4.5-5.5 by chromatofocusing
- 58. A method comprising contacting GS-7340 Ester Hydrolase with an organic compound in an in vitro or cell culture environment.
-
60. A composition comprising a substantially pure organic compound and isolated GS-7340 Ester Hydrolase.
- 61. A composition comprising an organic compound and GS-7340 Ester Hydrolase in an in vitro or cell culture environment.
- 62. In a method for identifying an anti-HIV therapeutic compound, the improvement comprising substituting a prototype compound with an esterified phosphonate or esterified carboxyl group to produce a candidate compound and assaying the resulting candidate compound for its anti-HIV activity.
Specification